Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alabama STEM News.
Press releases published on September 11, 2025
September 11, 2025
MKS Inc. Releases 2025 Environmental, Social, Governance Report
Indeterminate
GlobeNewswire
September 11, 2025
HAProxy Dominates G2 Fall 2025 Reports
Indeterminate
GlobeNewswire
September 11, 2025
Chilldyne and Carahsoft Partner to Deliver Risk-Free Liquid Cooling to Government Agencies Nationwide
Indeterminate
GlobeNewswire
September 11, 2025
Longer-Term Forecasts for Litecoin are More Optimistic with Bullish Expectations Suggested
Indeterminate
GlobeNewswire
September 11, 2025
Athira Pharma Announces Reverse Stock Split
Indeterminate
GlobeNewswire
September 11, 2025
AgEagle Aerial Systems Rebrands as EagleNXT to Drive Next Phase of Growth and Innovation
Indeterminate
GlobeNewswire
September 11, 2025
isolved Among Select Platinum Partners Integrated with Indeed’s New Talent Scout Solution
Indeterminate
GlobeNewswire
September 11, 2025
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
Indeterminate
GlobeNewswire
September 11, 2025
Shoals Technologies Group Secures a New Patent for BLA Architecture, Reinforcing American Intellectual Property
Indeterminate
GlobeNewswire
September 11, 2025
VERSES® Expands Commercial Relationship with Major Global Investment Firm
Indeterminate
GlobeNewswire
September 11, 2025
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium
Indeterminate
GlobeNewswire
September 11, 2025
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th
Indeterminate
GlobeNewswire
September 11, 2025
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring
Indeterminate
GlobeNewswire
September 11, 2025
Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming Medical Meetings
Indeterminate
GlobeNewswire